Burdick Daniel J, Marsters James C, Aliagas-Martin Ignacio, Stanley Mark, Beresini Maureen, Clark Kevin, McDowell Robert S, Gadek Thomas R
Department of Medicinal Chemistry, Genentech, Inc. 1 DNA Way, South San Francisco, CA 94080, USA.
Bioorg Med Chem Lett. 2004 May 3;14(9):2055-9. doi: 10.1016/j.bmcl.2004.02.046.
o-Bromobenzoyl l-tryptophan 1 inhibits the association of LFA-1 with ICAM-1 with an IC(50) of 1.7microM. Evaluation of the structure-activity relationship of the benzoyl moiety shows that 2,6-di-substitutions greatly enhance potency of this class of inhibitors. Electronegative substitutions that favor a 90 degrees angle between the benzoyl ring and the amide bond yield the most potent compounds. There is a strong correlation between the potency of the compounds and the difference between the ab initio energy at 90 degrees and the global minima energy for given compounds. Combining the favored benzoyl substitutions with l-histidine and l-asparagine resulted in a 15-fold increase in potency over compound 1.
邻溴苯甲酰基-L-色氨酸1抑制LFA-1与ICAM-1的结合,IC50为1.7微摩尔。对苯甲酰基部分的构效关系评估表明,2,6-二取代极大地增强了这类抑制剂的效力。有利于苯甲酰基环与酰胺键之间呈90度角的电负性取代产生了最有效的化合物。化合物的效力与给定化合物在90度时的从头算能量与全局最小能量之间的差异存在很强的相关性。将有利的苯甲酰基取代与L-组氨酸和L-天冬酰胺结合,使效力比化合物1提高了15倍。